The Latest News March 4, 2021 argenx Reports Full Year 2020 Financial Results and Provides Fourth Quarter Business Update Breda, the Netherlands argenx today reported financial results for the full year 2020 and provided a fourth quarter business update. Read More Press Releases News February 25, 2021 argenx to Report Full Year 2020 Financial Results and Fourth Quarter Business Update on March 4, 2021 argenx today announced that it will host a conference call and audio webcast on March 4, 2021 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its full year 2020 financial results and provide a fourth quarter business update. Read News February 5, 2021 argenx announces closing of global offering argenx SE announced today the closing of its previously announced global offering of an aggregate of 3,593,750 ordinary shares (including ordinary shares represented by American Depositary Shares (ADSs)), which includes the full exercise of the underwriters’ option to purchase 468,750 ordinary... Read News February 4, 2021 argenx announces full exercise of underwriters’ option to purchase additional ADSs argenx SE announced today that the underwriters of its previously announced global offering of ordinary shares (including ordinary shares represented by American Depositary Shares (ADSs)) have exercised their option to purchase 468,750 additional ADSs in full on the same terms and conditions as the... Read Media center ARGX-118 CIDP Cusatuzumab Efgartigimod Immune Thrombocytopenia Myasthenia Gravis Pemphigus Vulgaris SIMPLE Antibody Platform Facet Tags May 1, 2020 Making Asthma Crystal Clear April 16, 2020 Monoclonal antibodies against GARP/TGF-b1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo April 13, 2020 ARGX-116 / A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels April 8, 2020 Protein crystallization promotes type 2 immunity and is reversible by antibody treatment April 7, 2020 SIMPLE Antibody platform / DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops Load more
News February 25, 2021 argenx to Report Full Year 2020 Financial Results and Fourth Quarter Business Update on March 4, 2021 argenx today announced that it will host a conference call and audio webcast on March 4, 2021 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its full year 2020 financial results and provide a fourth quarter business update. Read
News February 5, 2021 argenx announces closing of global offering argenx SE announced today the closing of its previously announced global offering of an aggregate of 3,593,750 ordinary shares (including ordinary shares represented by American Depositary Shares (ADSs)), which includes the full exercise of the underwriters’ option to purchase 468,750 ordinary... Read
News February 4, 2021 argenx announces full exercise of underwriters’ option to purchase additional ADSs argenx SE announced today that the underwriters of its previously announced global offering of ordinary shares (including ordinary shares represented by American Depositary Shares (ADSs)) have exercised their option to purchase 468,750 additional ADSs in full on the same terms and conditions as the... Read
